Farnesyltransferase Inhibitor, Tipifarnib, Prevents Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure

Kazuhiro Shirozu(Harvard University), Fumito Ichinose(Harvard University), Shuichi Hirai(Nihon University), Shinsuke Hisaka(Massachusetts General Hospital), Masao Kaneki(Shriners Hospitals for Children - Erie), Tomokazu Tanaka(Shriners Hospitals for Children - Erie)
Cited by 14


Related Papers